We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
38.29%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$13.6M |
| 2 |
Merck
MRK
|
+$12.5M |
| 3 |
Intuitive Surgical
ISRG
|
+$11.1M |
| 4 |
DOCU
DocuSign
DOCU
|
+$10.9M |
| 5 |
Insulet
PODD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$6.86M |
| 3 |
Incyte
INCY
|
+$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.73M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16.13% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
651
Incyte
INCY
$24.4B
| – | – |
-101,377
| Closed | -$6.31M |
|
652
ING
ING
$101B
| – | – |
-16,019
| Closed | -$216K |
|
653
Ionis Pharmaceuticals
IONS
$9.15B
| – | – |
-6,178
| Closed | -$253K |
|
654
IonQ
IONQ
$15.6B
| – | – |
-333,277
| Closed | -$4.51M |
|
655
Samsara
IOT
$22.5B
| – | – |
-18,058
| Closed | -$500K |
|
656
Ingersoll Rand
IR
$34.7B
| – | – |
-20,418
| Closed | -$1.33M |
|
657
Iridium Communications
IRDM
$5.26B
| – | – |
-10,639
| Closed | -$661K |
|
658
Illinois Tool Works
ITW
$84.9B
| – | – |
-2,999
| Closed | -$750K |
|
659
Jacobs Solutions
J
$16.8B
| – | – |
-14,626
| Closed | -$1.44M |
|
660
JetBlue
JBLU
$2.42B
| – | – |
-19,014
| Closed | -$168K |
|
661
KB Home
KBH
$3.56B
| – | – |
-6,778
| Closed | -$350K |
|
662
KBR
KBR
$4.77B
| – | – |
-7,865
| Closed | -$512K |
|
663
CarMax
KMX
$8.16B
| – | – |
-34,636
| Closed | -$2.9M |
|
664
Legend Biotech
LEGN
$3.7B
| – | – |
-3,113
| Closed | -$215K |
|
665
Leslie's
LESL
$12.4M
| – | – |
-1,274
| Closed | -$239K |
|
666
Levi Strauss
LEVI
$9.43B
| – | – |
-13,955
| Closed | -$201K |
|
667
Li Auto
LI
$13.4B
| – | – |
-26,640
| Closed | -$935K |
|
668
L3Harris
LHX
$53.1B
| – | – |
-5,744
| Closed | -$1.12M |
|
669
Cheniere Energy
LNG
$53.9B
| – | – |
-2,018
| Closed | -$307K |
|
670
Grand Canyon Education
LOPE
$3.93B
| – | – |
-4,694
| Closed | -$484K |
|
671
LPL Financial
LPLA
$27.9B
| – | – |
-1,523
| Closed | -$331K |
|
672
Lattice Semiconductor
LSCC
$19.6B
| – | – |
-34,654
| Closed | -$3.33M |
|
673
Macy's
M
$6.89B
| – | – |
-15,531
| Closed | -$249K |
|
674
Masco
MAS
$15.2B
| – | – |
-11,437
| Closed | -$656K |
|
675
Mobileye
MBLY
$2.18B
| – | – |
-11,368
| Closed | -$437K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.
- Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
- Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
- Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
- Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
- Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
- Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
- Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.
Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.